TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe

K. Szymańska, L. E. Moore, N. Rothman, W. H. Chow, F. Waldman, E. Jaeger, T. Waterboer, L. Foretova, M. Navratilova, V. Janout, H. Kollarova, D. Zaridze, V. Matveev, D. Mates, N. Szeszenia-Dabrowska, I. Holcatova, V. Bencko, F. Le Calvez-Kelm, S. Villar, M. PawlitaP. Boffetta, P. Hainaut, P. Brennan

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'TP53, EGFR, and KRAS mutations in relation to VHL inactivation and lifestyle risk factors in renal-cell carcinoma from central and eastern Europe'. Together they form a unique fingerprint.

Medicine & Life Sciences